As studies suggest, older adults are at greater risk for being diagnosed with type 2 diabetes.
Two such complications are painful neuropathy and cardiomyopathy; both of which are common and progressive complications of diabetes. The symptoms of peripheral neuropathy include tingling, burning, lancinating pain, hyperesthesia, and allodynia.
The course of the disease progression may vary from intermittent, mild symptoms to severe chronic, and daily pain; which culminates into poor quality of life. Another complication of diabetes mellitus, diabetic cardiomyopathy, is defined as a ventricular dysfunction disorder that occurs in diabetic patients.
The development of the disease is characterized by a hidden subclinical period, during which cellular, structural changes and abnormalities lead to diastolic dysfunction, followed by systolic dysfunction, and terminating into heart failure. Left ventricular hypertrophy, metabolic abnormalities, extracellular matrix changes, small vessel disease, cardiac autonomic neuropathy, insulin resistance, oxidative stress, and apoptosis are the most important pathological advancements that lead to diabetic cardiomyopathy.
Various pharmaceutical agents from different pharmacological categories have been proposed for the symptomatic treatment of painful diabetic neuropathy; however, it is a herculean task to select a drug due to the wide range of choices and lack of consistent guidelines for treatment.
Similarly, treatment of cardiomyopathy is based on the general therapeutic rules of management of heart failure and no specifications have yet been addressed for this condition.
Therefore, more studies are required to improve our knowledge of these complex syndromes. From this perspective, this review is designed to delineate a general overview of neuropathy and cardiomyopathy, referring to the conventional therapies in use and possible unconventional, natural, herbal, and safe treatments for both the above-mentioned complications of diabetes.
Diabetes-a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract ; Zatalia SR, Sanusi H. The role of antioxidants in the pathophysiology, complications, and management of diabetes mellitus.
Acta Med Indones ; Diabetes - A Global Threat. Action in diabetes and vascular disease. J Hum Hypertens ;19 Suppl 1: WHO maps noncommunicable disease trends in all countries: Country profiles on noncommunicable disease trends in countries.
Cent Eur J Public Health ;19 3: Herbal therapies for Type 2 diabetes mellitus: Chemistry, biology, and potential application of selected plants and compounds. Evid Based Complement Alternat Med ; Socioeconomic inequalities in the incidence and prevalence of Type 2 diabetes mellitus in Europe.
Gac Sanit ;27 6:Doctor answers on Symptoms, Diagnosis, Treatment, and More: Dr. Hossain on nursing care plan diabetes mellitus type 2: In patients with type 2 dm, Insulin resistance is one of the factors in addition to decreasing Insulin production.
Recently published articles from Diabetes Research and Clinical Practice. are associated with higher prevalence of multiple diabetes-related autoantibodies in adults with type 1 diabetes Sodium-glucose cotransporter 2 inhibitors and fracture risk in patients with type 2 diabetes mellitus: A systematic literature review and Bayesian.
There are two types of diabetes-type 1 and type 2.
In type 1 diabetes, the body doesn't make insulin. This type of diabetes often develops before age Most people with diabetes have type 2, which usually develops in adults over age With type 2 diabetes, the body still makes insulin but the cells can't use it.
DIABETES RESEARCH PAPER ESSAY ] The REAL cause of Diabetes (Recommended),Diabetes Research Paper Essay Metformin lowers fasting blood glucose levels by commonly 25% postprandial blood glucose up to % as well as the HbA1c by an average of single.5%.
The review of literature for the present Study has been done on knowledge regarding lifestyle modification among diabetes mellitus patients from published articles, textbooks, reports, newsletters, medline and internet search. e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis.
It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.